CTLA4 and diabetes mellitus: Complementary evidence from chronic inflammatory and cardiovascular disease models shows progressive suppression of PD-1/PD-L1 and CTLA-4 signaling, supporting the concept that diabetes represents a systemic immune-checkpoint–impaired state [4].